Literature DB >> 15518048

Antiphospholipid (Hughes) syndrome.

Munther A Khamashta1, Maria Laura Bertolaccini, Graham R V Hughes.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15518048     DOI： 10.1080/08916930410001708706

Source DB:  PubMed          Journal:  Autoimmunity        ISSN： 0891-6934            Impact factor:   2.815


× No keyword cloud information.
  9 in total

Review 1.  Movement disorders in paraneoplastic and autoimmune disease.

Authors:  Jessica Panzer; Josep Dalmau
Journal:  Curr Opin Neurol       Date:  2011-08       Impact factor: 5.710

Review 2.  Hyperkinetic Movement Disorder Emergencies.

Authors:  Giovanni Cossu; Carlo Colosimo
Journal:  Curr Neurol Neurosci Rep       Date:  2017-01       Impact factor: 5.081

3.  Mania: psychiatric manifestations of the antiphospholipid syndrome.

Authors:  Haniya Raza; Steven A Epstein; Maryland Pao; Donald L Rosenstein
Journal:  Psychosomatics       Date:  2008 Sep-Oct       Impact factor: 2.386

Review 4.  Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria?

Authors:  Mohammad Hassan A Noureldine; Ali A Haydar; Ahmad Berjawi; Rody Elnawar; Ahmad Sweid; Munther A Khamashta; Graham R V Hughes; Imad Uthman
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

5.  Antiphospholipid syndrome: a case report with an unusual wide spectrum of clinical manifestations.

Authors:  Carmela Mazzoccoli; Domenico Comitangelo; Alessia D'Introno; Valeria Mastropierro; Carlo Sabbà; Antonio Perrone
Journal:  Auto Immun Highlights       Date:  2019-10-19

6.  Classifying and diagnosing systemic lupus erythematosus in the 21st century.

Authors:  Martin Aringer; Sindhu R Johnson
Journal:  Rheumatology (Oxford)       Date:  2020-12-05       Impact factor: 7.580

7.  Ocular disorders as the prevailing manifestations of antiphospholipid syndrome: a case series.

Authors:  Evangelia Tsironi; Nikolaos Gatselis; Maria G Kotoula; Kalliopi Zachou; Maria Pefkianaki; Fani Zacharaki; Dimitrios Z Chatzoulis; George N Dalekos
Journal:  Cases J       Date:  2009-10-20

8.  Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome.

Authors:  Hironari Hanaoka; Harunobu Iida; Tomofumi Kiyokawa; Yukiko Takakuwa; Takahiro Okazaki; Hidehiro Yamada; Shoichi Ozaki; Kimito Kawahata
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240

9.  Changes in Gut Microorganism in Patients with Positive Immune Antibody-Associated Recurrent Abortion.

Authors:  Min Jin; Dong Li; Rui Ji; Wen Liu; XiaoFei Xu; Xin Feng
Journal:  Biomed Res Int       Date:  2020-09-18       Impact factor: 3.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.